寵物診斷服務市場 - 全球產業規模、佔有率、趨勢、機會及預測（依檢測項目、類型、動物種類、地區及競爭格局分類，2021-2031年）

全球伴侶動物診斷服務市場預計將從 2025 年的 29.4 億美元成長到 2031 年的 44.9 億美元，複合年成長率為 7.31%。

這些服務包括臨床病理學、分子診斷和影像診斷，獸醫利用這些服務診斷和治療伴侶動物，包括犬、貓和馬。推動這些服務發展的主要因素是老齡化動物群體中慢性病發病率的上升，以及「寵物人性化」的趨勢——即飼主將寵物的醫療保健置於與人類同等的地位。此外，通用感染疾病的日益威脅也需要嚴格的監測和檢測，這使得這些診斷工具在現代獸醫學中顯得特別重要。

儘管存在這些成長要素，但市場仍面臨獸醫和病理學家嚴重短缺的問題，這限制了服務能力並增加了營運成本。這種短缺可能會延誤診斷結果的解讀，並限制高需求地區服務提供者的收入成長。然而，市場需求依然強勁。根據美國寵物用品協會 (APPA) 預測，到 2024 年，該行業預計將保持強勁成長勢頭，屆時美國獸醫護理支出和產品銷售額總合將達到 398 億美元。

市場促進因素

寵物人性化的趨勢是推動診斷服務需求成長的主要因素。隨著飼主越來越將寵物視為家庭成員，這種文化轉變直接促進了臨床服務的使用，從而增加了獸醫在疾病早期檢測、健康檢查和高級病理檢測方面的醫療費用支出，以確保動物健康。歐洲寵物食品協會 (FEDIAF) 的《2024 年事實與數據》報告也印證了這項高需求。該報告指出，截至 2024 年 6 月，歐盟約有 9,100 萬戶家庭將至少擁有一隻寵物，這將對獸醫基礎設施產生巨大需求，並確保診斷服務提供者擁有穩定的病例來源。

同時，寵物保險覆蓋範圍的擴大正在消除以往阻礙寵物獲得全面診斷服務的經濟障礙。保險選擇的增加使得飼主無需即時支付自付費用即可核准核磁共振成像（MRI）和分子檢測等昂貴的檢查，從而促進了從症狀治療向循證醫學的轉變。北美寵物健康保險協會（NAPHIA）發布的《2024年產業趨勢報告》也反映了這一趨勢，該報告指出，截至2024年5月，北美地區的保費總額達到了創紀錄的42.7億美元。這項影響在公司層級也顯而易見，IDEXX Laboratories報告稱，其伴侶動物部門2024年第三季的全球診斷經常性收入增加了7%。

市場挑戰

合格獸醫和病理學家的短缺造成了嚴重的營運瓶頸，並成為市場擴張的一大障礙。當診所和實驗室缺乏足夠的人員來執行操作和解讀複雜的影像診斷和分子檢測結果時，重要檢測結果的周轉時間會顯著延長。這些延誤迫使獸醫推遲治療決策，從而減少了他們能夠有效治療的病例數。因此，服務提供者無法充分利用檢測需求的激增，從而有效地限制了潛在的收入成長。

此外，人才短缺造成了嚴重的財務壓力，降低了利潤率，並限制了對拓展服務的投資。為了吸引有限的人才，獸醫診所被迫增加營運成本，通常採取提高工資和聘用高薪臨時工的方式。英國獸醫協會 (BVA) 2024 年的調查凸顯了這個問題，調查顯示，平均每家診所有 2.1 個全職獸醫職位空缺，約佔總員工人數的 23%。如此高的空缺率直接限制了診所處理診斷樣本的能力，抑制了整個市場的上升趨勢。

市場趨勢

人工智慧 (AI) 正日益融入獸醫實踐，以提高預測診斷的準確性並緩解人手不足的壓力。能夠自動分析複雜影像的 AI 技術可在診斷放射學中提供即時第二意見，從而加快診斷流程並消除操作瓶頸。這種應用正在加速發展；根據美國獸醫協會 (AVMA) 2025 年 2 月發布的報告《獸醫專業人員對人工智慧的理解、樂觀態度和應用：2024 年調查》，39.2% 的受訪者已在其專業實踐中使用 AI 工具，以幫助最佳化病例管理並促進快速治療性介入。

同時，非侵入性液態生物檢體技術的興起正在革新腫瘤學，只需簡單的抽血即可進行癌症篩檢，而無需進行侵入性的組織取樣。這項創新滿足了人們對便利的早期監測的需求，尤其適用於老年寵物，因為傳統切片檢查的風險對它們而言難以接受。 VolitionRx Limited 於 2025 年 3 月發布的《2024 年全年財務報告》證實了這項技術的商業性擴充性，該報告顯示，2024 年 Nu.Q Vet 癌症檢測的銷量約為 12 萬份。這一成長預示著人們正朝著預防性健康監測的方向轉變，從而能夠在臨床症狀惡化之前治療性介入。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章：全球寵物診斷服務市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 按檢測類型（臨床化學、微生物學、寄生蟲學、組織病理學、細胞病理學、血液學、免疫學/血清學、影像診斷、分子診斷、其他）
  • 依類型（照護現場(POC)、檢查室檢測）
  • 依動物種類（狗、貓、馬、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

6. 北美寵物診斷服務市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲寵物診斷服務市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區寵物診斷服務市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲寵物診斷服務市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲寵物診斷服務市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球寵物診斷服務市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• IDEXX Laboratories, Inc.
• Zoetis Inc.
• Virbac
• Heska Corporation
• Neogen Corporation
• Bio-Rad Laboratories, Inc.
• INDICAL Bioscience GmbH
• Agrolabo SpA
• ID.vet
• bioMerieux SA

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Companion Animal Diagnostic Services Market is projected to expand from USD 2.94 billion in 2025 to USD 4.49 billion by 2031, registering a CAGR of 7.31%. These services, which include clinical pathology, molecular diagnostics, and imaging, are utilized by veterinarians to diagnose and treat pets such as dogs, cats, and equines. Growth is largely fueled by the rising prevalence of chronic conditions in aging animal populations and the trend of pet humanization, where owners prioritize human-grade healthcare. Additionally, the increasing threat of zoonotic diseases necessitates strict surveillance and testing, further cementing the importance of these diagnostic tools in modern veterinary practice.

Despite these growth drivers, the market faces hurdles due to a severe global shortage of qualified veterinary professionals and pathologists, which limits service capacity and raises operational costs. This labor gap slows down diagnostic interpretation, potentially capping revenue generation for providers in high-demand areas. However, market demand remains strong; according to the American Pet Products Association, the sector saw robust activity in 2024, with spending on veterinary care and product sales reaching $39.8 billion in the United States.

Market Driver

The trend of pet humanization is a major catalyst for diagnostic service demand, as owners increasingly view their companion animals as integral family members. This cultural shift leads to a greater willingness to incur veterinary expenses for early disease detection, wellness screenings, and advanced pathology, directly increasing the utilization of clinical services to ensure animal health. Supporting this high demand, data from the FEDIAF EuropeanPetFood 'Facts & Figures 2024' report indicates that approximately 91 million European Union households owned at least one pet as of June 2024, creating a substantial need for veterinary care infrastructure and ensuring a steady stream of cases for diagnostic providers.

Concurrently, the expansion of pet insurance coverage is eliminating financial obstacles that historically restricted access to comprehensive diagnostic procedures. Broader insurance options encourage owners to authorize costly tests like MRI scans and molecular assays without the burden of immediate out-of-pocket expenses, fostering a shift from symptomatic treatment to evidence-based medicine. This trend is reflected in the North American Pet Health Insurance Association's 'State of the Industry Report 2024,' which noted a historic high of $4.27 billion in total premiums in North America by May 2024. The impact is visible corporately, with Idexx Laboratories reporting a 7 percent increase in global Companion Animal Group diagnostic recurring revenues in the third quarter of 2024.

Market Challenge

The scarcity of qualified veterinary professionals and pathologists presents a critical obstacle to market expansion by causing severe operational bottlenecks. When clinics and laboratories lack sufficient staff to perform procedures or interpret complex diagnostic images and molecular tests, turnaround times for critical results increase substantially. These delays force veterinarians to defer treatment decisions and reduce the volume of cases that can be managed effectively, preventing service providers from fully capitalizing on the surging demand for tests and effectively capping potential revenue growth.

Furthermore, this labor shortage creates intense financial pressure that erodes profit margins and restricts investment in service expansion. Veterinary practices are compelled to increase overhead costs to compete for limited talent, often resorting to higher wages or expensive temporary staffing. A 2024 survey by the British Veterinary Association highlighted this issue, revealing that clinical practices averaged 2.1 unfilled full-time equivalent veterinary roles, representing approximately 23% of their total workforce capacity. Such high vacancy rates directly constrain the physical ability of facilities to process diagnostic samples, thereby stalling the market's overall upward trajectory.

Market Trends

Artificial Intelligence (AI) is increasingly being integrated into veterinary workflows to enhance predictive diagnostics and alleviate the strain caused by workforce shortages. By automating complex image analysis, AI allows for immediate second opinions in radiology, thereby speeding up diagnostic processes and mitigating operational bottlenecks. This adoption is gaining momentum; the American Veterinary Medical Association's February 2025 report, 'Familiarity with artificial intelligence drives optimism and adoption among veterinary professionals: 2024 survey,' found that 39.2% of respondents are now utilizing AI tools for professional tasks, which helps optimize case management and facilitate faster treatment interventions.

In parallel, the rise of non-invasive liquid biopsy is revolutionizing oncology by permitting cancer screening through simple blood draws instead of invasive tissue sampling. This innovation addresses the need for accessible, early-stage monitoring, particularly for aging pets where traditional biopsy risks are prohibitive. The commercial scalability of this technology is evident in VolitionRx Limited's 'Full Fiscal Year 2024 Financial Results' from March 2025, which reported sales of approximately 120,000 Nu.Q Vet Cancer Tests in 2024. This growth signifies a broader pivot toward proactive wellness monitoring, allowing for therapeutic intervention before clinical symptoms escalate.

Key Market Players

• IDEXX Laboratories, Inc.
• Zoetis Inc.
• Virbac
• Heska Corporation
• Neogen Corporation
• Bio-Rad Laboratories, Inc.
• INDICAL Bioscience GmbH
• Agrolabo SpA
• ID.vet
• bioMerieux S.A.

Report Scope

In this report, the Global Companion Animal Diagnostic Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Companion Animal Diagnostic Services Market, By Testing

• Clinical Chemistry
• Microbiology
• Parasitology
• Histopathology
• Cytopathology
• Hematology
• Immunology & Serology
• Imaging
• Molecular Diagnostics
• Others

Companion Animal Diagnostic Services Market, By Type

• Point-of-Care (POC)
• Laboratory-based

Companion Animal Diagnostic Services Market, By Animal Type

• Dogs
• Cats
• Horses
• Others

Companion Animal Diagnostic Services Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Companion Animal Diagnostic Services Market.

Available Customizations:

Global Companion Animal Diagnostic Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Companion Animal Diagnostic Services Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Testing (Clinical Chemistry, Microbiology, Parasitology, Histopathology, Cytopathology, Hematology, Immunology & Serology, Imaging, Molecular Diagnostics, Others)
  • 5.2.2. By Type (Point-of-Care (POC), Laboratory-based)
  • 5.2.3. By Animal Type (Dogs, Cats, Horses, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Companion Animal Diagnostic Services Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Testing
  • 6.2.2. By Type
  • 6.2.3. By Animal Type
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Companion Animal Diagnostic Services Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Testing
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Animal Type
  • 6.3.2. Canada Companion Animal Diagnostic Services Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Testing
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Animal Type
  • 6.3.3. Mexico Companion Animal Diagnostic Services Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Testing
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Animal Type

7. Europe Companion Animal Diagnostic Services Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Testing
  • 7.2.2. By Type
  • 7.2.3. By Animal Type
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Companion Animal Diagnostic Services Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Testing
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Animal Type
  • 7.3.2. France Companion Animal Diagnostic Services Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Testing
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Animal Type
  • 7.3.3. United Kingdom Companion Animal Diagnostic Services Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Testing
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Animal Type
  • 7.3.4. Italy Companion Animal Diagnostic Services Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Testing
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Animal Type
  • 7.3.5. Spain Companion Animal Diagnostic Services Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Testing
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Animal Type

8. Asia Pacific Companion Animal Diagnostic Services Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Testing
  • 8.2.2. By Type
  • 8.2.3. By Animal Type
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Companion Animal Diagnostic Services Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Testing
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Animal Type
  • 8.3.2. India Companion Animal Diagnostic Services Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Testing
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Animal Type
  • 8.3.3. Japan Companion Animal Diagnostic Services Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Testing
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Animal Type
  • 8.3.4. South Korea Companion Animal Diagnostic Services Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Testing
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Animal Type
  • 8.3.5. Australia Companion Animal Diagnostic Services Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Testing
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Animal Type

9. Middle East & Africa Companion Animal Diagnostic Services Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Testing
  • 9.2.2. By Type
  • 9.2.3. By Animal Type
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Companion Animal Diagnostic Services Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Testing
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Animal Type
  • 9.3.2. UAE Companion Animal Diagnostic Services Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Testing
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Animal Type
  • 9.3.3. South Africa Companion Animal Diagnostic Services Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Testing
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Animal Type

10. South America Companion Animal Diagnostic Services Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Testing
  • 10.2.2. By Type
  • 10.2.3. By Animal Type
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Companion Animal Diagnostic Services Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Testing
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Animal Type
  • 10.3.2. Colombia Companion Animal Diagnostic Services Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Testing
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Animal Type
  • 10.3.3. Argentina Companion Animal Diagnostic Services Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Testing
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Animal Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Companion Animal Diagnostic Services Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. IDEXX Laboratories, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Zoetis Inc.
• 15.3. Virbac
• 15.4. Heska Corporation
• 15.5. Neogen Corporation
• 15.6. Bio-Rad Laboratories, Inc.
• 15.7. INDICAL Bioscience GmbH
• 15.8. Agrolabo SpA
• 15.9. ID.vet
• 15.10. bioMerieux S.A.

16. Strategic Recommendations

17. About Us & Disclaimer